In a #CuttingEdge article, researchers developed a monoclonal antibody that targets CD5L:p40 but not its individual subunits and observed efficacy in reducing an antigen-dependent Th2 response and airway inflammation. Learn more: https://ow.ly/u7mK50Z19vJ.
